US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Parabilis Medicines

39.36

-0.2200-0.56%

Pre-market: 39.25-0.1100-0.28%06:50 EDT

Volume:354.61K

Turnover:14.03M

Market Cap:4.88B

PE:-1.68

High:40.92

Open:39.41

Low:38.95

Close:39.58

52wk High:41.49

52wk Low:24.51

Shares:124.00M

Float Shares:33.50M

Volume Ratio:0.91

T/O Rate:1.06%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-23.4458

EPS(LYR):-60.0402

ROE:--

ROA:--

PB:4.66

PE(LYR):-0.66

Loading ...

Overview Company News Filings

Concept

no data

No relevant data is available

Capital Flow

Inflow:

Outflow:

News

Parabilis Medicines Q2 Loss Narrows; Shares Rise Pre-Bell

MT Newswires Live

Earnings Flash (PBLS) Parabilis Medicines Posts Q2 Net Loss $2.32 a Share

MT Newswires Live

Parabilis Medicines Q2 EPS $(2.32) Misses $(0.08) Estimate, Sales $148.000K Miss $25.000M Estimate

Benzinga Earnings

Parabilis Medicines: on Track to Initiate Desmoid Tumor Phase 3 Trial in H1 2027

THOMSON REUTERS

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers HK | Online Trading in stocks, bonds & ETFS","description":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","keywords":"tiger trading,tiger security,tiger broker hk,tigers co ltd,tiger trade hk,tiger brokers hk,stock broker,securities broker,online brokerage,hong kong broker,hk broker,online stock trading,online trading platform,stock trading platforms,trading application,stock trading,stock trading hong kong,buying stocks in hong kong,tiger brokers","social":{"ogDescription":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.gotigerhk.com/stock/PBLS"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"PBLS","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"PBLS\",,,,,undefined,":{"symbol":"PBLS","market":"US","secType":"STK","nameCN":"Parabilis Medicines","latestPrice":39.36,"timestamp":1787342400000,"preClose":39.58,"halted":0,"volume":354614,"hourTrading":{"tag":"盘前","latestPrice":39.25,"preClose":39.36,"latestTime":"06:50 EDT","volume":46,"amount":1801.410002,"timestamp":1787568655065,"change":-0.11,"changeRate":-0.002795,"amplitude":0.008892},"delay":0,"changeRate":-0.005558362809499719,"floatShares":33500000,"shares":124000000,"eps":-23.44581,"marketStatus":"Pre-Mkt","change":-0.22,"latestTime":"08-24 08:59:26 EDT","open":39.41,"high":40.915,"low":38.95,"amount":14033154.00656,"amplitude":0.049646,"askPrice":40,"askSize":1,"bidPrice":39.01,"bidSize":500,"shortable":3,"etf":0,"ttmEps":-23.44581,"tradingStatus":1,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1787578200000},"marketStatusCode":1,"adr":0,"listingDate":1781064000000,"exchange":"NASDAQ","adjPreClose":39.36,"preHourTrading":{"tag":"盘前","latestPrice":39.25,"preClose":39.36,"latestTime":"06:50 EDT","volume":46,"amount":1801.410002,"timestamp":1787568655065,"change":-0.11,"changeRate":-0.002795,"amplitude":0.008892},"postHourTrading":{"tag":"盘后","latestPrice":39.36,"preClose":39.36,"latestTime":"19:30 EDT","volume":1113,"amount":43800.34,"timestamp":1787355007379,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":0.9109418650720457,"impliedVol":0.6838,"impliedVolPercentile":0.5},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"PBLS\",,,,,undefined,":{"symbol":"PBLS","floatShares":33500000,"roa":"--","roe":"--","lyrEps":-60.040199,"volumeRatio":0.9109418650720457,"shares":124000000,"dividePrice":0,"high":40.915,"amplitude":0.049646,"preClose":39.58,"low":38.95,"week52Low":24.51,"pbRate":"4.66","psRate":"32977.30","week52High":41.4899,"institutionHeld":0,"latestPrice":39.36,"committee":0.996008,"eps":-23.44581,"divideRate":0,"volume":354614,"delay":0,"ttmEps":-23.44581,"open":39.41,"prevYearClose":20,"prevWeekClose":39.36,"prevMonthClose":33.98,"prevQuarterClose":27.37,"fiveDayClose":37.07,"twentyDayClose":31.28,"sixtyDayClose":20},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/PBLS\",params:#limit:5,,,undefined,":[{"market":"US","date":"2026-08-13","symbol":"PBLS","fiscalQuarterEnding":"2026/06","expectedEps":-0.16,"name":null,"time":"Pre-MKt","type":"earning","dateTimestamp":1786593600000,"reportTimeType":"pre","actualEps":-2.13}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"PBLS\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"PBLS\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.6,"buy":0.4,"hold":0,"sell":0,"strongSell":0,"meanLabel":"STRONG BUY","meanPercent":0.6,"analysts":5,"updateTime":1786766400000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/PBLS\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"PBLS","date":"2026-08-21","current":-1.678765,"percent":0.183673,"low":-31.159897,"twenty":-28.53843,"median":-25.283578,"eighty":-22.890572,"high":-15.535256,"avg":-25.511867,"sd":3.035266,"marketCap":4889445639},"quantilePoints":[{"date":"2026-06-12","current":-23.423744,"twenty":-24.021896,"median":-23.423744,"eighty":-18.690651,"marketCap":3580998591},{"date":"2026-06-18","current":-21.681158,"twenty":-23.280127,"median":-22.147598,"eighty":-21.001488,"marketCap":3314593719},{"date":"2026-06-26","current":-21.956025,"twenty":-22.933884,"median":-22.426629,"eighty":-21.561216,"marketCap":3356615076},{"date":"2026-07-02","current":-23.122126,"twenty":-23.423744,"median":-22.77646,"eighty":-21.681158,"marketCap":3534887500},{"date":"2026-07-10","current":-25.287743,"twenty":-24.420664,"median":-22.938881,"eighty":-21.956025,"marketCap":3865964860},{"date":"2026-07-17","current":-24.204934,"twenty":-24.912925,"median":-23.706058,"eighty":-22.147598,"marketCap":3700426180},{"date":"2026-07-24","current":-27.328421,"twenty":-25.279414,"median":-24.204934,"eighty":-22.705661,"marketCap":4177941603},{"date":"2026-07-31","current":-26.886968,"twenty":-25.665893,"median":-24.321545,"eighty":-22.738979,"marketCap":4110452756},{"date":"2026-08-07","current":-29.635636,"twenty":-26.527142,"median":-24.625564,"eighty":-22.753971,"marketCap":4530666328},{"date":"2026-08-14","current":-29.710599,"twenty":-28.289622,"median":-24.912925,"eighty":-22.788954,"marketCap":4542126698},{"date":"2026-08-21","current":-28.671719,"twenty":-28.53843,"median":-25.283578,"eighty":-22.890572,"marketCap":4889445639}],"updateTime":1787576366550},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"PBLS\",pageSize:4,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2659715159","title":"Parabilis Medicines Q2 Loss Narrows; Shares Rise Pre-Bell","url":"https://stock-news.laohu8.com/highlight/detail?id=2659715159","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659715159?lang=en_us&edition=fundamental","pubTime":"2026-08-13 19:46","pubTimestamp":1786621592,"startTime":"0","endTime":"0","summary":"Parabilis Medicines  reported a Q2 loss Thursday $2.32 per diluted share, compared a loss of $22.28 a year earlier.Analysts from FactSet expected a loss of $0.36.Collaboration revenue for the quarter ended June 30 was $148,000. The company did not report any revenue a year ago.As of June 30, the company has cash, cash equivalents and marketable securities of $1.1 billion, which it said are expected to fund its operations into 2030.Shares of the company were up over 6% in Thursday's premarket activity.Price: 39.99, Change: +2.58, Percent Change: +6.90","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["PBLS","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659159145","title":"Earnings Flash (PBLS) Parabilis Medicines Posts Q2 Net Loss $2.32 a Share","url":"https://stock-news.laohu8.com/highlight/detail?id=2659159145","media":"MT Newswires Live","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659159145?lang=en_us&edition=fundamental","pubTime":"2026-08-13 19:30","pubTimestamp":1786620615,"startTime":"0","endTime":"0","summary":"Earnings Flash (PBLS) Parabilis Medicines Posts Q2 Net Loss $2.32 a Share","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["PBLS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659159628","title":"Parabilis Medicines Q2 EPS $(2.32) Misses $(0.08) Estimate, Sales $148.000K Miss $25.000M Estimate","url":"https://stock-news.laohu8.com/highlight/detail?id=2659159628","media":"Benzinga Earnings","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659159628?lang=en_us&edition=fundamental","pubTime":"2026-08-13 19:29","pubTimestamp":1786620583,"startTime":"0","endTime":"0","summary":"Parabilis Medicines (NASDAQ:PBLS) reported quarterly losses of $(2.32) per share which missed the analyst consensus estimate of $(0.08) by 2800 percent. This is a 89.59 percent increase over losses of $(22.28) per share","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/news/earnings/26/08/61169752/parabilis-medicines-q2-eps-2-32-misses-0-08-estimate-sales-148-000k-miss-25-000m-estimate","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PBLS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659561101","title":"Parabilis Medicines: on Track to Initiate Desmoid Tumor Phase 3 Trial in H1 2027","url":"https://stock-news.laohu8.com/highlight/detail?id=2659561101","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659561101?lang=en_us&edition=fundamental","pubTime":"2026-08-13 19:00","pubTimestamp":1786618803,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260813:nTUA63DJYQ:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","PBLS"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":4,"totalPage":11,"pageCount":1,"totalSize":41,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/market/plate/belongs/PBLS\",params:#limit:6,delay:false,,,undefined,":[]}}